Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies

European Journal of Neurology

Volumn 6, Issue 1, 1999, Pages 71-77

  Willison, Hugh J ^a   Veitch, Jean ^a   Swan, Anthony V ^b   Baumann, Nicole ^c   Comi, Giancano ^d   Gregson, Norman A ^e   Illa, Isabel ^f   Jacobs, Bart C ^g   Zielasek, Jurgen ^g   Hughes, Richard A C ^e  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e GUY S HOSPITAL   (United Kingdom)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^g NONE

Author keywords

Autoantibodies; ELISA; GM1 ganglioside; GQ1b ganglioside; Guillain Barre syndrome; Miller Fisher syndrome; Multifocal motor neuropathy; Peripheral neuropathy

Indexed keywords

GANGLIOSIDE ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GUILLAIN BARRE SYNDROME; HUMAN; LABORATORY; MOTOR NEUROPATHY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SUBCLAVIAN STEAL SYNDROME;

EID: 0033032280     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1999.610071.x     Document Type: Article

References (15)

1. Adams D, Kuntzer T, Burger D, Chofflon M, Magistris MR, Regli F, Steck AJ (1991). Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases - a study of 180 sera. J Neuroimmunol 32:223-230.
2. Bansal AS, Abdulkarim B, Malik RA, Goulding P, Pumphrey RSH, Boulton AJM et al. (1994). IgM ganglioside GM1 antibodies in patients with autoimmune-disease or neuropathy, and controls. J Clin Pathol 47:300-302.
3. Bech E, Jakobsen J, Orntoft TF (1994). ELISA-type titertray assay of IgM anti-GM1 autoantibodies. Clin Chem 40:1331-1334.
4. Ben Younes-Chennoufi A, Meininger V, Leger JM, Bouche P, Jauberteau MO, Baumann N (1992). Antiganglioside antibodies in motor neuron diseases and peripheral neuropathies - study by ELISA technique and immunodetection on thin layer chromatography. Neurochem Int 20:353-357.
5. Chabraoui F, Derrington EA, Malliedidier F, Confavreux C, Quincy C, Caudie C (1993). Dot-blot immunodetection of antibodies against G(M1) and other gangliosides on PVDF-p membranes. J Immunol Methods 165:225-230.
6. Frey WH, Schmalz JW, Perfetti PA, Norris TL, Emory CR, Ala TA (1993). Silica-ELISA method improves detection and quantitation of minor glycolipid components in lipid mixtures and of other antigens. J Immunol Methods 164:275-283.
7. Hildebrandt, H (1996). Antigen-binding of anti-ganglioside antibodies in-vitro is strongly influenced by the ganglioside composition of the sample. FEBS Lett 388:29-33.
8. Marcus DM, Latov N, HSI BP, Gillard BK, participating laboratories (1989). Measurement and significance of antibodies against GM1 ganglioside. J Neuroimmunol 25:255-259.
9. Kornberg AJ, Pestronk A (1994). The clinical and diagnostic role of anti-GM(1) antibody testing. Muscle Nerve 17:100-104.
10. Pestronk A, Choksi R (1997) Multifocal motor neuropathy -serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology 49:1289-1292.
11. Ravindranath MH, Ravindranath RMH, Morton DL, Graves MC (1994). Factors affecting the fine specificity and sensitivity of serum anti-ganglioside antibodies in ELISA. J Immunol Methods 169:257-272.
12. Van Schaik IN, Bossuyt PMM, Brand A, Vermeulen M (1995). Diagnostic-value of GM(1) antibodies in motor-neuron disorders and neuropathies - a metaanalysis. Neurology 45:1570-1577.
13. Taylor BV, Gross L, Windebank AJ (1996). The sensitivity and specificity of anti-GM1 antibody testing. Neurology 47:951-955.
14. Willison HJ (1994). Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? J Neurol Neurosurg Psychiatry 57:1303-1307.
15. Zielasek J, Ritter G, Magi S, Hartung HP, Toyka KV (1994). A comparative trial of anti-glycoconjugate antibody-assays - IgM antibodies to GM1. J Neurol 241:475-480.